Manel Juan

Institució Catalana de Recerca i Estudis Avançats — Spain

Medicine · Health Sciences

52h-index12.8kcitations495works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(183), Multiple Myeloma Research and Treatments(78), Protein Degradation and Inhibitors(52), Cancer Immunotherapy and Biomarkers(47), Immune Cell Function and Interaction(47)

Publications489 total

Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition
Bone Marrow Transplantation·2025
Specific Instability of HLA-A*03:01 Expression in HEK-293 Cells
International Journal of Molecular Sciences·2025Open Access
The point-of-care network with the BCMA-directed CART ARI0002h (Cesnicabtagene Autoleucel) in patients with relapsed/refractory multiple myeloma maintains efficacy and safety in real-world data
Blood·2025Open Access
350 Long term survivors from Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC
Regular and Young Investigator Award Abstracts·2025Open Access
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial
ESMO Open·2025· 1 citedOpen Access
Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report
International Journal of Molecular Sciences·2025· 3 citedOpen Access
Adoptive transfer of NK cells engineered with a CD5-based chimeric antigen receptor (SRCD5CAR) to treat invasive fungal infections
Molecular Therapy·2025· 1 citedOpen Access
Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)
2025Open Access
Supplementary Figure 18 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Figure 4 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Figure 16 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Table 11 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Figure 3 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Table 16 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Figure 1 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Table 9 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Table 8 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Table 17 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Figure 12 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
Supplementary Figure 8 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025Open Access
page 1 of 25Next →

Frequent Co-authors

Jordi Yagüe(17), Juan I. Aróstegui(10), Álvaro Urbano-Ispizúa(9), Ricardo Pujol‐Borrell(8), Laia Alsina(7), Julio Delgado(7), Elı́as Campo(6), Mariona Pascal(6), Clàudia Fortuny(5), Esteve Trias(5), Daniel Benítez‐Ribas(5), Europa Azucena González‐Navarro(5), Roger Colobrán(5), Beatriz Martín-Antonio(5), Neus Villamor(4), Pedro Jares(4), Tycho Baumann(4), Marta Aymerich(4), Àngela Deyà‐Martínez(4), Jordi Vives(4)